<?xml version="1.0" encoding="UTF-8"?>
<p id="p0270">Dried blood spot (DBS) testing circumvents cold chain barriers due to its stability at high temperatures for 14 days and avoids the need for a trained phlebotomist to draw blood(69). DBS sampling in combination with centralised laboratory testing is accurate for HBsAg and HBV DNA measurement and should be supported by diagnostic test registration for DBS(70). Financial and technical support for development and implementation could be provided from industry partners and the Foundation for Innovative Diagnostics (FIND), while the WHO Essential Diagnostics List supports national investment in hepatitis B diagnostic testing(14).</p>
